APO Research

APO RESEARCH · REPORT

Voltaren

Selected research

Market Analysis & Forecast

Global Voltaren Market Analysis and Forecast 2026-2032

Market perspective

The global Voltaren market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Voltaren is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Voltaren is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Voltaren is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Voltaren is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Voltaren include Endo Pharmaceuticals, Enovachem Pharmaceuticals, Hainan Quanxing Pharmaceutical, Iroko Pharmaceuticals, Jewim Pharmaceutical, Supor South Ocean, GSK and Novartis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Voltaren, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Voltaren, also provides the sales of main regions and countries. Of the upcoming market potential for Voltaren, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Voltaren sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Voltaren market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Voltaren sales, projected growth trends, production technology, application and end-user industry.

Voltaren Segment by Company

Endo Pharmaceuticals

Enovachem Pharmaceuticals

Hainan Quanxing Pharmaceutical

Iroko Pharmaceuticals

Jewim Pharmaceutical

Supor South Ocean

GSK

Novartis

Voltaren Segment by Type

Injection

Tablet

Spray

Gel

Capsule

Voltaren Segment by Application

Elderly

Adults

Voltaren Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Voltaren market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Voltaren and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Voltaren.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Voltaren in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Voltaren manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Voltaren sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Voltaren Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injection Major Manufacturers Table 3. Tablet Major Manufacturers Table 4. Spray Major Manufacturers Table 5. Gel Major Manufacturers Table 6. Capsule Major Manufacturers Table 7. Global Voltaren Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Elderly Major Manufacturers Table 9. Adults Major Manufacturers Table 10. Voltaren Industry Trends Table 11. Voltaren Industry Drivers Table 12. Voltaren Industry Opportunities and Challenges Table 13. Voltaren Industry Restraints Table 14. Global Voltaren Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Voltaren Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Voltaren Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Voltaren Revenue Market Share by Region (2021-2026) Table 18. Global Voltaren Revenue Market Share by Region (2027-2032) Table 19. Global Voltaren Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Voltaren Sales by Region (2021-2026) & (K Units) Table 21. Global Voltaren Sales by Region (2027-2032) & (K Units) Table 22. Global Voltaren Sales Market Share by Region (2021-2026) Table 23. Global Voltaren Sales Market Share by Region (2027-2032) Table 24. Global Voltaren Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Voltaren Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Voltaren Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Voltaren Sales Market Share by Manufacturers (2021-2026) Table 28. Global Voltaren Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Voltaren Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Voltaren Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Voltaren Manufacturers, Product Type & Application Table 32. Global Voltaren Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Voltaren by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Voltaren Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Voltaren Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Voltaren Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Voltaren Revenue Market Share by Type (2021-2026) Table 39. Global Voltaren Revenue Market Share by Type (2027-2032) Table 40. Global Voltaren Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Voltaren Sales by Type (2021-2026) & (K Units) Table 42. Global Voltaren Sales by Type (2027-2032) & (K Units) Table 43. Global Voltaren Sales Market Share by Type (2021-2026) Table 44. Global Voltaren Sales Market Share by Type (2027-2032) Table 45. Global Voltaren Price by Type (2021-2026) & (US$/Unit) Table 46. Global Voltaren Price by Type (2027-2032) & (US$/Unit) Table 47. Global Voltaren Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Voltaren Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Voltaren Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Voltaren Revenue Market Share by Application (2021-2026) Table 51. Global Voltaren Revenue Market Share by Application (2027-2032) Table 52. Global Voltaren Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Voltaren Sales by Application (2021-2026) & (K Units) Table 54. Global Voltaren Sales by Application (2027-2032) & (K Units) Table 55. Global Voltaren Sales Market Share by Application (2021-2026) Table 56. Global Voltaren Sales Market Share by Application (2027-2032) Table 57. Global Voltaren Price by Application (2021-2026) & (US$/Unit) Table 58. Global Voltaren Price by Application (2027-2032) & (US$/Unit) Table 59. Endo Pharmaceuticals Company Information Table 60. Endo Pharmaceuticals Business Overview Table 61. Endo Pharmaceuticals Voltaren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Endo Pharmaceuticals Voltaren Product Portfolio Table 63. Endo Pharmaceuticals Recent Development Table 64. Enovachem Pharmaceuticals Company Information Table 65. Enovachem Pharmaceuticals Business Overview Table 66. Enovachem Pharmaceuticals Voltaren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Enovachem Pharmaceuticals Voltaren Product Portfolio Table 68. Enovachem Pharmaceuticals Recent Development Table 69. Hainan Quanxing Pharmaceutical Company Information Table 70. Hainan Quanxing Pharmaceutical Business Overview Table 71. Hainan Quanxing Pharmaceutical Voltaren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Hainan Quanxing Pharmaceutical Voltaren Product Portfolio Table 73. Hainan Quanxing Pharmaceutical Recent Development Table 74. Iroko Pharmaceuticals Company Information Table 75. Iroko Pharmaceuticals Business Overview Table 76. Iroko Pharmaceuticals Voltaren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Iroko Pharmaceuticals Voltaren Product Portfolio Table 78. Iroko Pharmaceuticals Recent Development Table 79. Jewim Pharmaceutical Company Information Table 80. Jewim Pharmaceutical Business Overview Table 81. Jewim Pharmaceutical Voltaren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Jewim Pharmaceutical Voltaren Product Portfolio Table 83. Jewim Pharmaceutical Recent Development Table 84. Supor South Ocean Company Information Table 85. Supor South Ocean Business Overview Table 86. Supor South Ocean Voltaren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Supor South Ocean Voltaren Product Portfolio Table 88. Supor South Ocean Recent Development Table 89. GSK Company Information Table 90. GSK Business Overview Table 91. GSK Voltaren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. GSK Voltaren Product Portfolio Table 93. GSK Recent Development Table 94. Novartis Company Information Table 95. Novartis Business Overview Table 96. Novartis Voltaren Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Novartis Voltaren Product Portfolio Table 98. Novartis Recent Development Table 99. North America Voltaren Revenue by Type (2021-2026) & (US$ Million) Table 100. North America Voltaren Revenue by Type (2027-2032) & (US$ Million) Table 101. North America Voltaren Sales by Type (2021-2026) & (K Units) Table 102. North America Voltaren Sales by Type (2027-2032) & (K Units) Table 103. North America Voltaren Sales Price by Type (2021-2026) & (US$/Unit) Table 104. North America Voltaren Sales Price by Type (2027-2032) & (US$/Unit) Table 105. North America Voltaren Revenue by Application (2021-2026) & (US$ Million) Table 106. North America Voltaren Revenue by Application (2027-2032) & (US$ Million) Table 107. North America Voltaren Sales by Application (2021-2026) & (K Units) Table 108. North America Voltaren Sales by Application (2027-2032) & (K Units) Table 109. North America Voltaren Sales Price by Application (2021-2026) & (US$/Unit) Table 110. North America Voltaren Sales Price by Application (2027-2032) & (US$/Unit) Table 111. North America Voltaren Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Voltaren Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 113. North America Voltaren Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 114. North America Voltaren Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 115. North America Voltaren Sales by Country (2021-2026) & (K Units) Table 116. North America Voltaren Sales by Country (2027-2032) & (K Units) Table 117. North America Voltaren Sales Price by Country (2021-2026) & (US$/Unit) Table 118. North America Voltaren Sales Price by Country (2027-2032) & (US$/Unit) Table 119. United States Voltaren Revenue (2021-2032) & (US$ Million) Table 120. Canada Voltaren Revenue (2021-2032) & (US$ Million) Table 121. Europe Voltaren Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Voltaren Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Voltaren Sales by Type (2021-2026) & (K Units) Table 124. Europe Voltaren Sales by Type (2027-2032) & (K Units) Table 125. Europe Voltaren Sales Price by Type (2021-2026) & (US$/Unit) Table 126. Europe Voltaren Sales Price by Type (2027-2032) & (US$/Unit) Table 127. Europe Voltaren Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Voltaren Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Voltaren Sales by Application (2021-2026) & (K Units) Table 130. Europe Voltaren Sales by Application (2027-2032) & (K Units) Table 131. Europe Voltaren Sales Price by Application (2021-2026) & (US$/Unit) Table 132. Europe Voltaren Sales Price by Application (2027-2032) & (US$/Unit) Table 133. Europe Voltaren Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Voltaren Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. Europe Voltaren Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. Europe Voltaren Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 137. Europe Voltaren Sales by Country (2021-2026) & (K Units) Table 138. Europe Voltaren Sales by Country (2027-2032) & (K Units) Table 139. Europe Voltaren Sales Price by Country (2021-2026) & (US$/Unit) Table 140. Europe Voltaren Sales Price by Country (2027-2032) & (US$/Unit) Table 141. Germany Voltaren Revenue (2021-2032) & (US$ Million) Table 142. France Voltaren Revenue (2021-2032) & (US$ Million) Table 143. U.K. Voltaren Revenue (2021-2032) & (US$ Million) Table 144. Italy Voltaren Revenue (2021-2032) & (US$ Million) Table 145. Netherlands Voltaren Revenue (2021-2032) & (US$ Million) Table 146. China Voltaren Revenue by Type (2021-2026) & (US$ Million) Table 147. China Voltaren Revenue by Type (2027-2032) & (US$ Million) Table 148. China Voltaren Sales by Type (2021-2026) & (K Units) Table 149. China Voltaren Sales by Type (2027-2032) & (K Units) Table 150. China Voltaren Sales Price by Type (2021-2026) & (US$/Unit) Table 151. China Voltaren Sales Price by Type (2027-2032) & (US$/Unit) Table 152. China Voltaren Revenue by Application (2021-2026) & (US$ Million) Table 153. China Voltaren Revenue by Application (2027-2032) & (US$ Million) Table 154. China Voltaren Sales by Application (2021-2026) & (K Units) Table 155. China Voltaren Sales by Application (2027-2032) & (K Units) Table 156. China Voltaren Sales Price by Application (2021-2026) & (US$/Unit) Table 157. China Voltaren Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Asia Voltaren Revenue by Type (2021-2026) & (US$ Million) Table 159. Asia Voltaren Revenue by Type (2027-2032) & (US$ Million) Table 160. Asia Voltaren Sales by Type (2021-2026) & (K Units) Table 161. Asia Voltaren Sales by Type (2027-2032) & (K Units) Table 162. Asia Voltaren Sales Price by Type (2021-2026) & (US$/Unit) Table 163. Asia Voltaren Sales Price by Type (2027-2032) & (US$/Unit) Table 164. Asia Voltaren Revenue by Application (2021-2026) & (US$ Million) Table 165. Asia Voltaren Revenue by Application (2027-2032) & (US$ Million) Table 166. Asia Voltaren Sales by Application (2021-2026) & (K Units) Table 167. Asia Voltaren Sales by Application (2027-2032) & (K Units) Table 168. Asia Voltaren Sales Price by Application (2021-2026) & (US$/Unit) Table 169. Asia Voltaren Sales Price by Application (2027-2032) & (US$/Unit) Table 170. Asia Voltaren Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Asia Voltaren Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Asia Voltaren Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Asia Voltaren Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. Asia Voltaren Sales by Country (2021-2026) & (K Units) Table 175. Asia Voltaren Sales by Country (2027-2032) & (K Units) Table 176. Asia Voltaren Sales Price by Country (2021-2026) & (US$/Unit) Table 177. Asia Voltaren Sales Price by Country (2027-2032) & (US$/Unit) Table 178. Japan Voltaren Revenue (2021-2032) & (US$ Million) Table 179. South Korea Voltaren Revenue (2021-2032) & (US$ Million) Table 180. India Voltaren Revenue (2021-2032) & (US$ Million) Table 181. Australia Voltaren Revenue (2021-2032) & (US$ Million) Table 182. China Taiwan Voltaren Revenue (2021-2032) & (US$ Million) Table 183. Southeast Asia Voltaren Revenue (2021-2032) & (US$ Million) Table 184. SAMEA Voltaren Revenue by Type (2021-2026) & (US$ Million) Table 185. SAMEA Voltaren Revenue by Type (2027-2032) & (US$ Million) Table 186. SAMEA Voltaren Sales by Type (2021-2026) & (K Units) Table 187. SAMEA Voltaren Sales by Type (2027-2032) & (K Units) Table 188. SAMEA Voltaren Sales Price by Type (2021-2026) & (US$/Unit) Table 189. SAMEA Voltaren Sales Price by Type (2027-2032) & (US$/Unit) Table 190. SAMEA Voltaren Revenue by Application (2021-2026) & (US$ Million) Table 191. SAMEA Voltaren Revenue by Application (2027-2032) & (US$ Million) Table 192. SAMEA Voltaren Sales by Application (2021-2026) & (K Units) Table 193. SAMEA Voltaren Sales by Application (2027-2032) & (K Units) Table 194. SAMEA Voltaren Sales Price by Application (2021-2026) & (US$/Unit) Table 195. SAMEA Voltaren Sales Price by Application (2027-2032) & (US$/Unit) Table 196. SAMEA Voltaren Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. SAMEA Voltaren Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. SAMEA Voltaren Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. SAMEA Voltaren Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 200. SAMEA Voltaren Sales by Country (2021-2026) & (K Units) Table 201. SAMEA Voltaren Sales by Country (2027-2032) & (K Units) Table 202. SAMEA Voltaren Sales Price by Country (2021-2026) & (US$/Unit) Table 203. SAMEA Voltaren Sales Price by Country (2027-2032) & (US$/Unit) Table 204. Brazil Voltaren Revenue (2021-2032) & (US$ Million) Table 205. Argentina Voltaren Revenue (2021-2032) & (US$ Million) Table 206. Chile Voltaren Revenue (2021-2032) & (US$ Million) Table 207. Colombia Voltaren Revenue (2021-2032) & (US$ Million) Table 208. Peru Voltaren Revenue (2021-2032) & (US$ Million) Table 209. Saudi Arabia Voltaren Revenue (2021-2032) & (US$ Million) Table 210. Israel Voltaren Revenue (2021-2032) & (US$ Million) Table 211. UAE Voltaren Revenue (2021-2032) & (US$ Million) Table 212. Turkey Voltaren Revenue (2021-2032) & (US$ Million) Table 213. Iran Voltaren Revenue (2021-2032) & (US$ Million) Table 214. Egypt Voltaren Revenue (2021-2032) & (US$ Million) Table 215. Key Raw Materials Table 216. Raw Materials Key Suppliers Table 217. Voltaren Distributors List Table 218. Voltaren Customers List Table 219. Research Programs/Design for This Report Table 220. Authors List of This Report Table 221. Secondary Sources Table 222. Primary Sources List of Figures Figure 1. Voltaren Image Figure 2. Global Voltaren Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Voltaren Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injection Image Figure 5. Tablet Image Figure 6. Spray Image Figure 7. Gel Image Figure 8. Capsule Image Figure 9. Global Voltaren Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Voltaren Market Size Share 2021 VS 2025 VS 2032 Figure 11. Elderly Image Figure 12. Adults Image Figure 13. Global Voltaren Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Voltaren Revenue (2021-2032) & (US$ Million) Figure 15. Global Voltaren Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Voltaren Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Voltaren Revenue Market Share by Region (2021-2032) Figure 18. Global Voltaren Sales (2021-2032) & (K Units) Figure 19. Global Voltaren Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Voltaren Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Voltaren Sales YoY (2021-2032) & (K Units) Figure 22. Europe Voltaren Sales YoY (2021-2032) & (K Units) Figure 23. China Voltaren Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Voltaren Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Voltaren Sales YoY (2021-2032) & (K Units) Figure 26. Global Voltaren Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Voltaren Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Voltaren Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Voltaren Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Voltaren Revenue Market Share by Type (2021-2032) Figure 32. Global Voltaren Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Voltaren Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Voltaren Sales Market Share by Type (2021-2032) Figure 35. Global Voltaren Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Voltaren Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Voltaren Revenue Market Share by Application (2021-2032) Figure 38. Global Voltaren Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Voltaren Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Voltaren Sales Market Share by Application (2021-2032) Figure 41. North America Voltaren Revenue Share by Type (2021-2032) Figure 42. North America Voltaren Sales Share by Type (2021-2032) Figure 43. North America Voltaren Revenue Share by Application (2021-2032) Figure 44. North America Voltaren Sales Share by Application (2021-2032) Figure 45. North America Voltaren Revenue Share by Country (2021-2032) Figure 46. North America Voltaren Sales Share by Country (2021-2032) Figure 47. Europe Voltaren Revenue Share by Type (2021-2032) Figure 48. Europe Voltaren Sales Share by Type (2021-2032) Figure 49. Europe Voltaren Revenue Share by Application (2021-2032) Figure 50. Europe Voltaren Sales Share by Application (2021-2032) Figure 51. Europe Voltaren Revenue Share by Country (2021-2032) Figure 52. Europe Voltaren Sales Share by Country (2021-2032) Figure 53. China Voltaren Revenue Share by Type (2021-2032) Figure 54. China Voltaren Sales Share by Type (2021-2032) Figure 55. China Voltaren Revenue Share by Application (2021-2032) Figure 56. China Voltaren Sales Share by Application (2021-2032) Figure 57. Asia Voltaren Revenue Share by Type (2021-2032) Figure 58. Asia Voltaren Sales Share by Type (2021-2032) Figure 59. Asia Voltaren Revenue Share by Application (2021-2032) Figure 60. Asia Voltaren Sales Share by Application (2021-2032) Figure 61. Asia Voltaren Revenue Share by Country (2021-2032) Figure 62. Asia Voltaren Sales Share by Country (2021-2032) Figure 63. SAMEA Voltaren Revenue Share by Type (2021-2032) Figure 64. SAMEA Voltaren Sales Share by Type (2021-2032) Figure 65. SAMEA Voltaren Revenue Share by Application (2021-2032) Figure 66. SAMEA Voltaren Sales Share by Application (2021-2032) Figure 67. SAMEA Voltaren Revenue Share by Country (2021-2032) Figure 68. SAMEA Voltaren Sales Share by Country (2021-2032) Figure 69. Voltaren Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Voltaren Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Tablet
  • Spray
  • Gel
  • Capsule
Applications
  • Elderly
  • Adults
Companies covered
  • Endo Pharmaceuticals
  • Enovachem Pharmaceuticals
  • Hainan Quanxing Pharmaceutical
  • Iroko Pharmaceuticals
  • Jewim Pharmaceutical
  • Supor South Ocean
  • GSK
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Voltaren Market by Type
  3. 1.2.1 Global Voltaren Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injection
  5. 1.2.3 Tablet
  6. 1.2.4 Spray
  7. 1.2.5 Gel
  8. 1.2.6 Capsule
  9. 1.3 Voltaren Market by Application
  10. 1.3.1 Global Voltaren Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Elderly
  12. 1.3.3 Adults
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Voltaren Market Dynamics
  1. 2.1 Voltaren Industry Trends
  2. 2.2 Voltaren Industry Drivers
  3. 2.3 Voltaren Industry Opportunities and Challenges
  4. 2.4 Voltaren Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Voltaren Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Voltaren Revenue by Region
  3. 3.2.1 Global Voltaren Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Voltaren Revenue by Region (2021-2026)
  5. 3.2.3 Global Voltaren Revenue by Region (2027-2032)
  6. 3.2.4 Global Voltaren Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Voltaren Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Voltaren Sales by Region
  9. 3.4.1 Global Voltaren Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Voltaren Sales by Region (2021-2026)
  11. 3.4.3 Global Voltaren Sales by Region (2027-2032)
  12. 3.4.4 Global Voltaren Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Voltaren Revenue by Manufacturers
  2. 4.1.1 Global Voltaren Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Voltaren Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Voltaren Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Voltaren Sales by Manufacturers
  6. 4.2.1 Global Voltaren Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Voltaren Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Voltaren Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Voltaren Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Voltaren Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Voltaren Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Voltaren Manufacturers, Product Type & Application
  13. 4.7 Global Voltaren Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Voltaren Market CR5 and HHI
  16. 4.8.2 2025 Voltaren Tier 1, Tier 2, and Tier 3
5 Voltaren Market by Type
  1. 5.1 Global Voltaren Revenue by Type
  2. 5.1.1 Global Voltaren Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Voltaren Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Voltaren Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Voltaren Sales by Type
  6. 5.2.1 Global Voltaren Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Voltaren Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Voltaren Sales Market Share by Type (2021-2032)
  9. 5.3 Global Voltaren Price by Type
6 Voltaren Market by Application
  1. 6.1 Global Voltaren Revenue by Application
  2. 6.1.1 Global Voltaren Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Voltaren Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Voltaren Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Voltaren Sales by Application
  6. 6.2.1 Global Voltaren Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Voltaren Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Voltaren Sales Market Share by Application (2021-2032)
  9. 6.3 Global Voltaren Price by Application
7 Company Profiles
  1. 7.1 Endo Pharmaceuticals
  2. 7.1.1 Endo Pharmaceuticals Company Information
  3. 7.1.2 Endo Pharmaceuticals Business Overview
  4. 7.1.3 Endo Pharmaceuticals Voltaren Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Endo Pharmaceuticals Voltaren Product Portfolio
  6. 7.1.5 Endo Pharmaceuticals Recent Developments
  7. 7.2 Enovachem Pharmaceuticals
  8. 7.2.1 Enovachem Pharmaceuticals Company Information
  9. 7.2.2 Enovachem Pharmaceuticals Business Overview
  10. 7.2.3 Enovachem Pharmaceuticals Voltaren Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Enovachem Pharmaceuticals Voltaren Product Portfolio
  12. 7.2.5 Enovachem Pharmaceuticals Recent Developments
  13. 7.3 Hainan Quanxing Pharmaceutical
  14. 7.3.1 Hainan Quanxing Pharmaceutical Company Information
  15. 7.3.2 Hainan Quanxing Pharmaceutical Business Overview
  16. 7.3.3 Hainan Quanxing Pharmaceutical Voltaren Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Hainan Quanxing Pharmaceutical Voltaren Product Portfolio
  18. 7.3.5 Hainan Quanxing Pharmaceutical Recent Developments
  19. 7.4 Iroko Pharmaceuticals
  20. 7.4.1 Iroko Pharmaceuticals Company Information
  21. 7.4.2 Iroko Pharmaceuticals Business Overview
  22. 7.4.3 Iroko Pharmaceuticals Voltaren Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Iroko Pharmaceuticals Voltaren Product Portfolio
  24. 7.4.5 Iroko Pharmaceuticals Recent Developments
  25. 7.5 Jewim Pharmaceutical
  26. 7.5.1 Jewim Pharmaceutical Company Information
  27. 7.5.2 Jewim Pharmaceutical Business Overview
  28. 7.5.3 Jewim Pharmaceutical Voltaren Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Jewim Pharmaceutical Voltaren Product Portfolio
  30. 7.5.5 Jewim Pharmaceutical Recent Developments
  31. 7.6 Supor South Ocean
  32. 7.6.1 Supor South Ocean Company Information
  33. 7.6.2 Supor South Ocean Business Overview
  34. 7.6.3 Supor South Ocean Voltaren Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Supor South Ocean Voltaren Product Portfolio
  36. 7.6.5 Supor South Ocean Recent Developments
  37. 7.7 GSK
  38. 7.7.1 GSK Company Information
  39. 7.7.2 GSK Business Overview
  40. 7.7.3 GSK Voltaren Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 GSK Voltaren Product Portfolio
  42. 7.7.5 GSK Recent Developments
  43. 7.8 Novartis
  44. 7.8.1 Novartis Company Information
  45. 7.8.2 Novartis Business Overview
  46. 7.8.3 Novartis Voltaren Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Novartis Voltaren Product Portfolio
  48. 7.8.5 Novartis Recent Developments
8 North America
  1. 8.1 North America Voltaren Market Size by Type
  2. 8.1.1 North America Voltaren Revenue by Type (2021-2032)
  3. 8.1.2 North America Voltaren Sales by Type (2021-2032)
  4. 8.1.3 North America Voltaren Price by Type (2021-2032)
  5. 8.2 North America Voltaren Market Size by Application
  6. 8.2.1 North America Voltaren Revenue by Application (2021-2032)
  7. 8.2.2 North America Voltaren Sales by Application (2021-2032)
  8. 8.2.3 North America Voltaren Price by Application (2021-2032)
  9. 8.3 North America Voltaren Market Size by Country
  10. 8.3.1 North America Voltaren Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Voltaren Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Voltaren Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Voltaren Market Size by Type
  2. 9.1.1 Europe Voltaren Revenue by Type (2021-2032)
  3. 9.1.2 Europe Voltaren Sales by Type (2021-2032)
  4. 9.1.3 Europe Voltaren Price by Type (2021-2032)
  5. 9.2 Europe Voltaren Market Size by Application
  6. 9.2.1 Europe Voltaren Revenue by Application (2021-2032)
  7. 9.2.2 Europe Voltaren Sales by Application (2021-2032)
  8. 9.2.3 Europe Voltaren Price by Application (2021-2032)
  9. 9.3 Europe Voltaren Market Size by Country
  10. 9.3.1 Europe Voltaren Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Voltaren Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Voltaren Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Voltaren Market Size by Type
  2. 10.1.1 China Voltaren Revenue by Type (2021-2032)
  3. 10.1.2 China Voltaren Sales by Type (2021-2032)
  4. 10.1.3 China Voltaren Price by Type (2021-2032)
  5. 10.2 China Voltaren Market Size by Application
  6. 10.2.1 China Voltaren Revenue by Application (2021-2032)
  7. 10.2.2 China Voltaren Sales by Application (2021-2032)
  8. 10.2.3 China Voltaren Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Voltaren Market Size by Type
  2. 11.1.1 Asia Voltaren Revenue by Type (2021-2032)
  3. 11.1.2 Asia Voltaren Sales by Type (2021-2032)
  4. 11.1.3 Asia Voltaren Price by Type (2021-2032)
  5. 11.2 Asia Voltaren Market Size by Application
  6. 11.2.1 Asia Voltaren Revenue by Application (2021-2032)
  7. 11.2.2 Asia Voltaren Sales by Application (2021-2032)
  8. 11.2.3 Asia Voltaren Price by Application (2021-2032)
  9. 11.3 Asia Voltaren Market Size by Country
  10. 11.3.1 Asia Voltaren Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Voltaren Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Voltaren Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Voltaren Market Size by Type
  2. 12.1.1 SAMEA Voltaren Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Voltaren Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Voltaren Price by Type (2021-2032)
  5. 12.2 SAMEA Voltaren Market Size by Application
  6. 12.2.1 SAMEA Voltaren Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Voltaren Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Voltaren Price by Application (2021-2032)
  9. 12.3 SAMEA Voltaren Market Size by Country
  10. 12.3.1 SAMEA Voltaren Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Voltaren Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Voltaren Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Voltaren Value Chain Analysis
  2. 13.1.1 Voltaren Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Voltaren Production Mode & Process
  6. 13.2 Voltaren Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Voltaren Distributors
  9. 13.2.3 Voltaren Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research